Healio

OnabotulinumtoxinA improves masseter muscle prominence

Please provide your email address to receive an email when new articles are posted on . OnabotulinumtoxinA treatment showed a marked reduction in masseter muscle prominence with both 48- and 72-unit ...
Seeking Alpha

Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China

IRVINE, Calif., Sept. 11, 2024 /PRNewswire/ -- Allergan Aesthetics, an AbbVie (ABBV) company, today announced that BOTOX ® Cosmetic (onabotulinumtoxinA) is now available for the treatment of masseter ...
Longview News-Journal

Dr. Alexander Rivkin Co-Authors Landmark Phase 2B Study on OnabotulinumtoxinA for Masseter Muscle Prominence Published in Aesthetic Surgery Journal

Internationally renowned aesthetic expert Dr. Alexander Rivkin contributes to groundbreaking research demonstrating the safety and efficacy of Botox® treatment for masseter muscle prominence reduction ...
Nasdaq

Allergan Aesthetics Launches BOTOX® Cosmetic (onabotulinumtoxinA) for Masseter Muscle Prominence (MMP) in Adults in China

BOTOX® Cosmetic is the first neurotoxin approved in China for the treatment of masseter muscle prominence (MMP), the largest global market for MMP. Approval supported by well-established safety ...